Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
December 14, 2011
|
December 13, 2011
|
November 29, 2011
|
November 4, 2011
|
|
November 1, 2011
|
September 29, 2011
|
September 28, 2011
|
September 27, 2011
|